Accessibility Menu
Willow Biosciences logo

Willow Biosciences(TSX) WLLW

Current PriceN/A
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-99%
5 Year-97%
1 Year-33%
1 Month-10%
Willow Biosciences last closing stock price
MetricPriceDate
Last closeCAD 0.142026-07-22
Willow Biosciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%CAD 0.142026-07-15
1 month-10%CAD 0.152026-06-22
3 month-18.18%CAD 0.172026-04-21
Year to date-18.18%CAD 0.172025-12-31
1 year-32.5%CAD 0.202025-07-22
3 year-76.52%CAD 0.582023-07-21
5 year-96.93%CAD 4.402021-07-23
Since inception-99.1%CAD 15.002019-04-15

Willow Biosciences Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$5.34M

Net Income (TTM)

-CA$2.09M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 11, 2025

WLLW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Willow Biosciences

Willow Biosciences, Inc. is a biotechnology company, which engages in the research, development, and commercialization of plant derived ingredients for consumer care, food and beverage, and pharmaceutical products. It operates through the Canada and The Rest of the World, and Unites States geographical segments. The company was founded on April 15, 1981 and is headquartered in Calgary, Canada.

Industry

Biotechnology

Sector

Health Care

Employees

16

CEO

Mark Hodgson

Website

atlas-corp.ca

Headquarters

Calgary, AB T2R 0Y6, CA

WLLW Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-72.88%

Net Income Margin

3.01%

Return on Equity

0.38%

Return on Capital

-408.66%

Return on Assets

0.18%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

CA$4.63M

Operating Income

-CA$3.37M

EBITDA

-CA$2.60M

Operating Cash Flow

-CA$3.16M

Capital Expenditure

-CA$20.00K

Free Cash Flow

-CA$3.18M

Cash & ST Invst.

CA$29.22M

Total Debt

CA$0.00

Willow Biosciences Performance Analysis

Willow Biosciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 821,000517.3%
20232023-12-31CAD 1,172,00042.8%
20242024-12-31CAD 0N/A
20252025-12-31CAD 0N/A
Willow Biosciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-09-3066.0%
Q42024-12-3110.5%
Q12025-03-31-6.5%
Q22025-06-30-100.0%
Willow Biosciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.60134.2%
20232023-12-31CAD -0.52-12.5%
20242024-12-31CAD -0.08-83.9%
20252025-12-31CAD -0.01-91.2%
Willow Biosciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-09-3033.8%
Q42024-12-31-3.4%
Q12025-03-3175.8%
Q22025-06-30-559.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

CA$0.00

-100.0%

Gross Profit

CA$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

19

N/A

Net Income

CA$370.00K

+121.9%

EBITDA

-CA$891.00K

+18.8%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

CA$29.22M

+2772.8%

Total Debt

CA$0.00

-100.0%

Accounts Receivable

CA$86.00K

+561.5%

Inventory

CA$0.00

-100.0%

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$0.00

-100.0%

Return on Assets

0.18%

N/A

Return on Invested Capital

-4.46%

N/A

Free Cash Flow

-CA$1.88M

-156.5%

Operating Cash Flow

-CA$1.88M

-156.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,510.84+0.00%
^DJIDJI
$52,306.84+0.00%
^IXICNASDAQ
$25,750.82-0.00%
BTCBitcoin
$65,855.00-0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.00+0.04%
SMCISuper Micro Computer
$30.56+0.20%
AALAmerican Airlines Group
$14.79-0.03%
NOKNokia
$10.28-0.03%

Questions About WLLW

What is the current price of Willow Biosciences?

Willow Biosciences is trading at N/A per share.

What is the 52-week range for Willow Biosciences?

Over the past 52 weeks, Willow Biosciences has traded between N/A and N/A.

How much debt does Willow Biosciences have?

As of the most recent reporting period, Willow Biosciences reported total debt of CA$0.00.

How much cash does Willow Biosciences have on hand?

Willow Biosciences reported CA$26.68M in cash and cash equivalents in its most recent financial results.

What is Willow Biosciences’s dividend yield?

Willow Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services